Executive Summary
New Zealand 's HPV Immunization Program has the potential, long haul, to avoid cervical growth for 2 ladies consistently, sparing more than 30 experience each year. In New Zealand, roughly 160 ladies are determined to have cervical malignancy every year and 60 ladies bite the dust from it. Māori ladies are twice as prone to get cervical disease, and just about three times as prone to pass on of it, contrasted with non-Māori ladies. More than 99 percent of all cervical malignancy is connected to contamination with Human Papillomavirus (HPV). Presently with the accessibility of an antibody which is profoundly useful against the HPV sorts in charge of roughly 70% cervical tumours, there is an imperative open door for the essential aversion of cervical malignancy. Cervical screening will proceed to be fundamental in averting cervical tumour brought on by other HPV sorts, and for those who pass up a great opportunity for inoculation. The HPV Immunization Program can possibly lessen ethnic disparities in cervical growth. A reasonable spotlight on accomplishing value for those with most noteworthy need and at most elevated danger of passing up a major opportunity for inoculation or screening projects is basic. The objective of the HPV Immunization Program is to actualize a fair, continuous inoculation program for young ladies in school year 8 (or age 12 if not conveyed in a school based system), and a get up to speed program for young ladies conceived on or after
The human papillomavirus (HPV) is a sexually transmitted disease (STD) that is very common throughout the United States and worldwide (World Health Organization (WHO), 2016). There are over 100 different forms of the virus with 13 of these types being capable of causing cancer (WHO, 2016). HPV can lead to the development of serious health problems. Theses health problems are especially an issue for adolescent women due to the highly increasing STD rates among this age group (Kostas-Polston, Johnson-Mallard & Berman, 2012). There is a vaccine for many of the common types of HPV, however, many parents are refusing to vaccinate their daughters for various reasons. With the rising cases of STDs, less birth
The unforgettable story of vaccines is a story of triumph and controversy. The saddest part of the story is persistent ignorance and a lack of education, comingled with the personal need of some parents to explain away the problems of their children, have caused the controversy to arise. The good news is that the triumphant reality of vaccines as a whole is still the larger enduring legacy. The human papillomavirus vaccine is not an exception to this rule; in fact despite all the controversy surrounding the vaccine, it is one of medicine’s greatest lifesaving gifts to us.
HPV vaccinations bring up many public health and ethical issues. Some states want to require vaccines for school attendance. In the academic journal article “HPV Vaccination’s Second Act: Promotion, Competition, and Compulsion”, author Jason Schwartz states that, “Although some argue that HPV vaccines should never be mandated for school attendance, the temptation for policymakers to revisit this ethical and policy debate must be resisted until HPV vaccination has successfully become a routine, trusted component of adolescent medical care” (Schwartz). This train of thought exemplifies the opposition to HPV vaccination in this country, which restricts us in immunizing possible victims as effectively as possible. If the ignorance towards the vaccine continues, there will not be a powerful impact in decreasing rates of HPV infections.
Many parents and organizations are opposed to this policy because they feel that it is an infringement on personal choice. While religious exemptions to HPV vaccination are allowed by the law, there is no built in policy for exemptions based on personal secular values. Some vegan families, for example, may feel uncomfortable vaccinating their children since animals are involved in the research and development of several vaccines, including the HPV vaccine. Individuals against animal testing, or recombinant DNA technology (Gardasil (Human Papillomavirus Vaccine) Questions and Answers, 2006) could feel uneasy about the Gardasil vaccine as well (Gardasil 9, 2014). In addition, some fear that this policy will “promot[e] promiscuity” (Marsa,
HPV is by far the most common sexually transmitted infection in the United States. Per the Centers for Disease Control and Prevention (CDC), 50 percent of all sexually active men and women will get it at some point in their lives, and 20 million already have it. A vaccine is available that prevents 70% of cervical cancers that arise from sexual intercourse. The human papillomavirus is unknowingly common and is diagnosed in 10,000 women a year, causing 4,000 deaths per year (“HPV Question and Answers”). If we take the responsibility to vaccinate young girls and boys, to be safe, we can eliminate many unnecessary deaths. This vaccine is a great discovery that should be put to good use, the HPV vaccine should be mandated in young teens everywhere.
Should schools require students to have the HPV vaccine? Human Papilloma Virus better known as HPV is a sexually transmitted infection that has the slight chance of becoming cervical cancer. Requiring that the vaccination for HPV be administered at the age of eleven before entering school is unjust and in reality unnecessary. The vaccine only protects against HPV for four to five years. Most eleven year olds do not even think about sex, and by the time they do have sex the vaccine is no longer effective in preventing HPV. The vaccine also cost upwards to four hundred dollars making families that can not afford it have to either go into debt or avoid the vaccine. Parents should be the ones to decide wether a child gets the vaccine.
Current evidence-based practice involves providing vaccinations as they protect the child for a lifetime (Joanna Briggs Foundation, 2009). Secondary prevention involves early screening for cervical cancer related to the HPV infection. Early screening for cervical cancer is crucial as cervical with women over the age of 30 according to evidence-based practice as the rates of HPV are higher (Agency for Healthcare Research and Quality, 2011). Tertiary prevention focuses on minimizing the effects of HPV. For example, mental health programs assist the individual with coping with the diagnosis of HPV. These levels of prevention are crucial for assisting those with the diagnosis of HPV and the community health nurse has an important role in educating these individuals to prevent further health
There are many ethical and legal issues that count against a mandatory HPV vaccination for all girls aged 11-12 years old. First, the long-term safety and effectiveness of the vaccination is unknown (Javitt et al., 2008). Clinical trials conducted on the HPV vaccine concluded no short-term adverse effects, but as more girls and young women begin to get the vaccine some adverse effects may appear (Javitt et al., 2008). The extent immunity of the HPV vaccine is also unclear. Studies have shown the vaccine to be present in 3-4 year follow-ups, but the long-term effectiveness has not been studied (Javitt et al., 2008). Furthermore, HPV has a long incubation period, which would only affect a small amount of individuals many years after they finish school (Stewart, 2008).
Prophylactic vaccination against high risk human papilloma virus 16 and 18 represents an exciting means of protection against HPV related malignancy. However, this strategy alone, even if there is a level of cross protection against other oncogenic viruses, cannot completely prevent cervical cancer. In some countries cervical screening programs have reduced the incidence of invasive cervical cancer by up to 80 percent although this decline has now reached a plateau with current cancers occurring in patients who have failed to attend for screening or where the sensitivity of the tests have proved inadequate. Cervical screening is inevitably associated with significant anxiety for the many women who require investigation and treatment following abnormal cervical cytology. However, it is vitally important to stress the need for continued cervical screening to complement vaccination in order to optimize prevention in vaccines and prevent cervical cancer in older women where the value of vaccination is currently unclear. It is likely that vaccination will ultimately change the natural history of HPV disease by reducing the influence of the highly oncogenic types HPV 16 and 18. In the long term this is likely to lead to an increase in recommended screening intervals. HPV vaccination may also reduce
There are many reasons that this vaccine could be beneficial, not only to our society, but to many of the underdeveloped nations of the world in which HPV and cervical cancer are still considered to be an epidemic (MacDonald). It could save the young women who get the vaccine from the future trouble of dealing with a highly invasive cancer, as well as protect them from the embarrassment that comes with contracting a venereal disease. However, the controversy of this topic is not in whether the vaccine is a benefit to women’s health, which many, including the FDA and the Centers for Disease Control, believe that it is; but in the debate over whether it is the parents’ right, not the states’, to choose what is best for their child. The question of mandatory vaccination raises medical, moral and legal issues that are not easily reconcilable (Lovinger). Many parents are opposed to the mandating of this vaccine for three reasons. First, HPV is not spread by casual contact, as are the other diseases that children are vaccinated against for the safety of the classrooms. Second, the vaccine has only been approved for a short while, thus not all of the side effects and long term effects are known. Last, parents are afraid that by getting their child vaccinated against a sexually transmitted disease they will be encouraging promiscuity. Gardasil would become the first vaccine mandated for school-aged children that targets a
According to the Journal of the American Medical Association, 80% of people in America are infected by the Human Papillomavirus, also known as HPV, at some point in their lifetime. That would be as though, 25 out of the 30 students in this classroom have or have had this sexually transmitted disease. Only one group of desks in this class would be safe from its harmful effects. This is an incredibly common, and potentially deadly, virus, which is why we should mandate the HPV vaccine, Gardasil, for all teenage girls entering middle school.
I have chosen this paper since one of my goals during the Integrated Practicum was to gain knowledge about cancer prevention and management in the community settings. I believe that this article might increase my understanding about the usage of HPV Vaccines in prevention of various types of cancer.
The HPV vaccine is cancer prevention. Over thousands of cases of HPV cancers are detected every year in men and women. The HPV vaccination is important because it can prevent these cancers. The United States Food and Drug Administration approved this vaccine and it is one hundred percent safe. This vaccine is preventive care for the second leading cancer in women. It has been proven to be one hundred percent effective in prevention of cervical cancer, but the vaccine must be given to children between the age of 11 -17 before they become sexually active. After the age seventeen with young women most become sexually active and receive their first pap smear from their gynecologist, receiving the vaccine at this point is not as effective in prevention of cancers. Another benefit of receiving the vaccine during adolescent, is it supports people who may not have the medical knowledge or access to regular medical services.
Cervical cancer is one of the highly popular disease for the women. Different programmes has been made up to fight against this deadly disease. New Zealand has one of the best screening programmes in the world. The establishment of National Cervical Cancer Screening Programme in NZ in 1990 had reduced a significant number of 60% of women who develop cervical cancer and who die from it since it was built. More than 1 million New Zealander women are enrolled in this programme and 95 % are eligible. The Cervical Cancer screening programme aims to; informing women about the importance of having the cervical screening tests; promoting cervical screening tests on a regular basis to women aged 20–70; ensuring high-quality and culturally appropriate services; supporting women with abnormal tests; ensuring there is regular monitoring to see that the goals of the programme are being met. The NCSP also acknowledges the importance of the Treaty of Waitangi in providing a screening programme that is successful for all New Zealand women.
Among the many arguments for mandatory HPV vaccination, the foremost is that it is an important medical achievement and a major public health milestone. This vaccine has proven to be one-hundred percent effective in preventing the 4 HPV strains that are responsible for seventy percent of cervical cancers and ninety percent of genital warts. In addition, no serious side effects have been identified. Because this vaccine is a preventive measure, administration before onset of sexual activity is ideal; however, even females who have been sexually active can still benefit from this vaccination (Perkins et al., 2010). Nationally and internationally, the HPV vaccine will significantly reduce disease burden by reducing monetary and psychological costs of invasive procedures that remove precancerous and cancerous lesions. By combining vaccination with routine Pap smear screening, these public health efforts have the remarkable opportunity to eradicate cervical cancer (Ramet et al., 2011).